We identified biomarkers of response to therapies that help overcome PARPi resistance using patient-derived models of breast and ovarian cancer. Thanks AstraZeneca, Instituto de Salud Carlos III (ISCIII), Fundación Fero, @ghd, AACR and collaborators!!! aacrjournals.org/clincancerres/…